Literature DB >> 7547225

Evidence for mutual interdependence of epithelium and stromal lymphoid cells in a subset of papillary carcinomas.

M H Takahashi1, G A Thomas, E D Williams.   

Abstract

We have correlated the morphological features of 30 human thyroid carcinomas with the cellular localisation of insulin-like growth factor 1 (IGF-1) mRNA and IGF-1 receptor peptide using in situ hybridisation with digoxigenin-labelled oligoprobes and immunohistochemistry. Four of the five follicular carcinomas studied showed a consistent, uniform, strong positivity for IGF-1 mRNA in tumour cells compared with weakly positive surrounding normal follicular tissue and negative stroma. The majority of papillary carcinomas showed weak to moderate epithelial positivity for IGF-1 mRNA and negative stroma. Immunohistochemistry for IGF-1 receptor showed moderate positivity confined to the tumour epithelial cells in both follicular and the majority of papillary carcinomas. However, in a subgroup of papillary carcinomas characterised by a diffuse stromal lymphoid infiltration (n = 5), the stromal cells showed a much stronger reactivity for IGF-1 mRNA than the tumour or background thyroid, and the tumour cells showed a uniformly high level of immunoreactivity for IGF-1 receptor. These results are compatible with the growth of the papillary carcinoma in these cases being the result of a symbiotic relationship between the stromal lymphoid cells and the tumour epithelium with the lymphoid cells responding to an antigen produced by the tumour cells and the tumour cells responding to a growth factor produced by the lymphoid infiltrate. We suggest that this mechanism may be important in other tumours regularly associated with a widespread lymphoid infiltrate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7547225      PMCID: PMC2034040          DOI: 10.1038/bjc.1995.418

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Up-regulation of IGF-I receptors on IM-9 cells by IGF-II peptides.

Authors:  G A Werther; R L Hintz; R G Rosenfeld
Journal:  Horm Metab Res       Date:  1989-03       Impact factor: 2.936

2.  Control of human thyroid follicular cell proliferation in suspension and monolayer culture.

Authors:  D W Williams; D Wynford-Thomas; E D Williams
Journal:  Mol Cell Endocrinol       Date:  1987-05       Impact factor: 4.102

3.  High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.

Authors:  I Bongarzone; M A Pierotti; N Monzini; P Mondellini; G Manenti; R Donghi; S Pilotti; M Grieco; M Santoro; A Fusco
Journal:  Oncogene       Date:  1989-12       Impact factor: 9.867

4.  A role for insulin-like growth factor-I in the regulation of human thyroid cell growth by thyrotrophin.

Authors:  C A Ollis; D J Hill; D S Munro
Journal:  J Endocrinol       Date:  1989-12       Impact factor: 4.286

5.  Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer.

Authors:  D Yee; S Paik; G S Lebovic; R R Marcus; R E Favoni; K J Cullen; M E Lippman; N Rosen
Journal:  Mol Endocrinol       Date:  1989-03

6.  Evidence for autocrine production of IGF-1 in human thyroid adenomas.

Authors:  D W Williams; E D Williams; D Wynford-Thomas
Journal:  Mol Cell Endocrinol       Date:  1989-01       Impact factor: 4.102

7.  High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.

Authors:  N R Lemoine; E S Mayall; F S Wyllie; E D Williams; M Goyns; B Stringer; D Wynford-Thomas
Journal:  Oncogene       Date:  1989-02       Impact factor: 9.867

8.  The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases.

Authors:  J R Jass; W S Atkin; J Cuzick; H J Bussey; B C Morson; J M Northover; I P Todd
Journal:  Histopathology       Date:  1986-05       Impact factor: 5.087

9.  Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis.

Authors:  H R Harach; D A Escalante; A Onativia; J Lederer Outes; E Saravia Day; E D Williams
Journal:  Acta Endocrinol (Copenh)       Date:  1985-01

10.  Loss of dependence on IGF-1 for proliferation of human thyroid adenoma cells.

Authors:  D W Williams; E D Williams; D Wynford-Thomas
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

View more
  4 in total

1.  Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer.

Authors:  Rulla M Tamimi; Graham A Colditz; Yihong Wang; Laura C Collins; Rong Hu; Bernard Rosner; Hanna Y Irie; James L Connolly; Stuart J Schnitt
Journal:  Breast Cancer Res Treat       Date:  2011-01-01       Impact factor: 4.872

2.  Expression and significance of IGF-1 and IGF-1R in thyroid nodules.

Authors:  Ying-Jian Liu; Wei Qiang; Jing Shi; Si-Qing Lv; Mei-Ju Ji; Bing-Yin Shi
Journal:  Endocrine       Date:  2013-01-04       Impact factor: 3.633

Review 3.  IGF Bioregulation System in Benign and Malignant Thyroid Nodular Disease: A Systematic Review.

Authors:  Apostolos Karagiannis; Eva Kassi; Antonios Chatzigeorgiou; Michael Koutsilieris
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

4.  Contribution of socioeconomic and environmental factors to geographic disparities in breast cancer risk in the Nurses' Health Study II.

Authors:  Verónica M Vieira; Trang VoPham; Kimberly A Bertrand; Peter James; Natalie DuPré; Rulla M Tamimi; Francine Laden; Jaime E Hart
Journal:  Environ Epidemiol       Date:  2019-12-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.